THORNTON, Colo., June 27, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) (“Ascent” or the “Company”), the leading U.S. innovator in the design and manufacture of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, today announced the pricing of a public offering of an aggregate of 1,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,000,000 shares of common stock (the “Warrants”), at a combined pu ...

BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of its previously announced underwritten public offering of 6,604,507 shares of its common stock. The total gross proceeds from the offering to the Company are expected to be approximately $85 million. In addition, CorMedix granted the underwriters a 30-day o ...

随着政策端利好的持续释放，2025年以来，我国基础设施公募REITs（以下简称"C-REITs"）呈现出了 一、二级市场"双轮驱动"的火爆格局。 业内人士指出，站在逾2000亿元规模的高地之上，C-REITs将以更快的步伐向前拓进。当然，"热行 情"背后仍需"冷思考"，投资者应密切关注产品基本面变化，可选择在市场给予REITs稳定的估值后再进 行买入操作，避免盲目追高。 项目密集"涨停" 在低利率环境以及优质资产稀缺的大背景下，今年以来，具备相对稳健收益的C-REITs投资价值日益凸 显。 由REITs投资价值和市场整体供需关系改善所驱动的一、二级市场的火爆行情仍在持续演绎。 一级市场方面，6月26日上市的中金亦庄产业园封闭式基础设施证券投资基金（以下简称"中金亦庄产业 园REIT"）开盘即因上市首日盘中和收盘价达到了30%的涨跌幅限制而宣布停牌。 根据交易所发布的公告，为了保护基金份额持有人的利益，中金亦庄产业园REIT将自2025年6月27日上 海证券交易所开市起停牌1小时，并于当日上午10:30起复牌。 无独有偶，因涨幅超过限制而停牌的情况今年可谓屡见不鲜。 例如，6月17日，华夏基金华润有巢REIT同 ...

HDB's $1.5 billion initial public offering, one of India’s biggest this year, sold out amid demand from wealthy investors seeking to buy a piece of the shadow-lending unit of the country’s top private bank https://t.co/PsHG069vVq ...

Tiburon, CA, June 26, 2025 (GLOBE NEWSWIRE) -- FIGX Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 13,100,000 units. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading tomorrow, June 27, 2025, under the ticker symbol “FIGXU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the closing of its previously announced public offering of an aggregate of 4,000,000 of the Company’s ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company’s ordinary shares, at a combined public offe ...

NETANYA, Israel, June 26, 2025 /PRNewswire/ -- TAT Technologies Ltd. (Nasdaq: TATT) (TASE: TATT) ("TAT" or the "Company"), a leading provider of products and services to the commercial and military aerospace and ground defense industries, announced today that, in connection with its previously announced underwritten public offering of 4,150,000 ordinary shares (consisting of 1,625,000 ordinary shares sold and issued by TAT and 2,525,000 ordinary shares sold by FIMI Opportunity V, L.P. and FIMI Israel Opport ...

New York, June 26, 2025 (GLOBE NEWSWIRE) -- Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under ...

Core Viewpoint - CorMedix Inc. plans to offer and sell $85.0 million of its common stock in an underwritten public offering, with a potential additional 15% option for underwriters [1][2] Group 1: Offering Details - The offering is subject to market conditions, and there is no assurance regarding its completion or terms [1] - RBC Capital Markets is acting as the sole bookrunner for the offering [2] - The net proceeds will be used for general corporate purposes, including working capital and research expenses [2] Group 2: Regulatory Information - The securities are being offered under a shelf registration statement filed with the SEC on May 6, 2024, and declared effective on May 22, 2024 [3] - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and available on their website [4] Group 3: Company Overview - CorMedix is focused on developing therapeutic products for life-threatening conditions, with its lead product DefenCath® approved by the FDA on November 15, 2023 [6] - DefenCath was commercially launched in inpatient settings in April 2024 and in outpatient settings in July 2024 [6] - The company plans to commence clinical studies in Total Parenteral Nutrition and Pediatric populations in 2025 [6]

Core Viewpoint - Globavend Holdings Limited is conducting a public offering to raise approximately $15 million to support its e-commerce logistics operations and future growth initiatives [1][4]. Group 1: Offering Details - The offering consists of 21,739,130 ordinary shares or pre-funded warrants, each sold with one Series A Warrant and one Series B Warrant [2]. - The purchase price for each ordinary share and accompanying warrants is set at $0.69, while the pre-funded warrants are priced slightly lower [3]. - The Series A Warrants have an initial exercise price of $0.69 and expire one year after their initial exercise date, while the Series B Warrants have an exercise price of $1.173 and also expire one year after their initial exercise date [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for capital expenditures, increasing operating capacity, working capital, general corporate purposes, purchasing warehouses, and potential mergers and acquisitions [4]. Group 3: Company Overview - Globavend Holdings Limited is an emerging e-commerce logistics provider offering end-to-end logistics solutions primarily in Hong Kong, Australia, and New Zealand [6]. - The company serves enterprise customers, facilitating business-to-consumer (B2C) transactions and providing integrated cross-border logistics services [6].